Shanghai Securities News China Securities Network News - According to the Ministry of Commerce on March 22, on March 21, Minister of Commerce Wang Wentao met with David A. Ricks, Chairman and CEO of Eli Lilly and Company. The two parties exchanged views on China-US economic and trade relations and the development of Eli Lilly and Company in China.
Wang Wentao stated that health is an important indicator of people's better life, and China adheres to a people-centered approach, steadily advancing the construction of Healthy China. As the world's second-largest pharmaceutical consumer market, China will create vast opportunities for multinational pharmaceutical companies, including Eli Lilly and Company. Having deeply invested in China for many years, Eli Lilly and Company hopes to continue investing in China, providing more high-quality pharmaceutical products and services, and contributing to the well-being of the people and the development of the pharmaceutical industry. China adheres to promoting high-quality development through high-level opening up, continuously creating a first-class business environment that is market-oriented, law-based, and internationalized, ensuring excellent services for foreign enterprises.
David A. Ricks introduced the global business development of Eli Lilly and Company, expressed high attention to the Chinese market, and stated that the company will continue to increase investment and R&D cooperation in China, providing better products and services for the Chinese market.